The direct involvement of NF-κB in melanoma response to immunotherapy was recently confirmed using a multi-scale network approach to discover gene modules with coordinated gene expression upon the treatment with the immunotherapy drug nivolumab [183]. Here, NFKB1 is linked to melanoma.